Literature DB >> 16082636

Granulomatous lung disease occurring during etanercept treatment.

Kristine Phillips1, Michael Weinblatt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16082636     DOI: 10.1002/art.21336

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  9 in total

1.  Drug-induced granulomatous interstitial nephritis in a patient with ankylosing spondylitis during therapy with adalimumab.

Authors:  Peter Korsten; Nadera J Sweiss; Ulf Nagorsnik; Timothy B Niewold; Hermann-Josef Gröne; Oliver Gross; Gerhard A Müller
Journal:  Am J Kidney Dis       Date:  2010-10-25       Impact factor: 8.860

Review 2.  Sarcoid-like granulomatosis in patients treated with anti-TNFα factors. A case report and review of the literature.

Authors:  Theoni Kanellopoulou; Anna Filiotou; Hariklia Kranidioti; Spyridon P Dourakis
Journal:  Clin Rheumatol       Date:  2010-10-23       Impact factor: 2.980

3.  Etanercept related pseudo-empyema in rheumatoid arthritis.

Authors:  Doron Rimar; Michael Rozenbaum; Gleb Slobodin; Nina Boulman; Itzhak Rosner
Journal:  Clin Rheumatol       Date:  2010-02-03       Impact factor: 2.980

4.  Tumor necrosis factor-alpha (TNF-α)-blockade-induced hepatic sarcoidosis in psoriatic arthritis (PsA): case report and review of the literature.

Authors:  Raquel Cuchacovich; Joseph Hagan; Tahir Khan; Arthur Richert; Luis R Espinoza
Journal:  Clin Rheumatol       Date:  2010-10-01       Impact factor: 2.980

5.  Development of sarcoidosis 6-month post discontinuation of etanercept: coincidence or real association?

Authors:  Muhammad Haroon; John G Ryan; Sinead Harney
Journal:  Clin Rheumatol       Date:  2011-03-08       Impact factor: 2.980

Review 6.  Pulmonary complications of tumor necrosis factor-targeted therapy.

Authors:  Krishna Thavarajah; Peggy Wu; Elisa J Rhew; Anjana K Yeldandi; David W Kamp
Journal:  Respir Med       Date:  2009-02-07       Impact factor: 3.415

7.  Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis.

Authors:  S K Metyas; R M Tadros; D G Arkfeld
Journal:  Rheumatol Int       Date:  2008-09-02       Impact factor: 2.631

8.  Development of sarcoidosis following etanercept treatment: a report of three cases.

Authors:  Inger Marie Skoie; Klaus Wildhagen; Roald Omdal
Journal:  Rheumatol Int       Date:  2010-01-09       Impact factor: 2.631

9.  Recombinant paracoccin reproduces the biological properties of the native protein and induces protective Th1 immunity against Paracoccidioides brasiliensis infection.

Authors:  Ana Claudia Paiva Alegre; Aline Ferreira Oliveira; Fausto Bruno Dos Reis Almeida; Maria Cristina Roque-Barreira; Ebert Seixas Hanna
Journal:  PLoS Negl Trop Dis       Date:  2014-04-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.